PANDEMRIX 3.75mcg / 0.5ml suspension + emulsion for injection emulsion medication leaflet

J07BB02 • pre-pandemic flu vaccine • Antiinfectives for systemic use | Viral vaccines | Influenza vaccines

The pre-pandemic influenza vaccine is used to prevent infections caused by influenza virus strains that pose a high risk of causing a pandemic. This type of vaccine is developed based on influenza virus strains identified as having pandemic potential, such as H5N1 (avian flu) or H7N9.

The vaccine contains inactivated viral antigens or protein subunits that stimulate the immune system to produce specific antibodies against these strains. It is administered intramuscularly, usually in two doses, a few weeks apart.

The vaccine is recommended for individuals at high risk, such as healthcare workers, personnel involved in epidemic control, and those working with birds or other susceptible animals.

Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. The pre-pandemic influenza vaccine is an important preventive measure for reducing the risk of influenza pandemics and protecting public health.